Healthcare Opportunity in ABBV

3 months ago

Mark Ren

"Beginning with stock number one, which is going to be AVY, stock ticker ABBV. And when it comes to AVY, it's one of my favorite positions in my portfolio, one of my longest held positions in my portfolio, and a top performing healthcare company. That was until recently. And we're getting a little bit of a sell-off that could have me sniffing opportunity. The company currently has a market cap of $374 billion, making it the largest company we're going to look at today. And over the past 12 months, shares are up 8%. Year-to-date though, up 21%. However, since the stock hit a record high of nearly $245 back at the beginning of October, shares of AVY have fell roughly 12%. If we got this stock price down closer to the $200 level, that would be a fantastic entry point. Analysts rate the stock a buy with an average 12-month price target of $244, implying nearly 15% upside and a dividend yield of nearly 3.5%."

The speaker highlights ABBV as a top healthcare pick currently undergoing a sell-off. He notes strong historical performance, significant revenue figures, and a tactical entry point if the price drops closer to $200, supported by a buy rating and a 12-month price target indicating 15% upside.

Related Stocks